Skip to main content
. 2022 Sep 14;42(37):7152–7165. doi: 10.1523/JNEUROSCI.0312-22.2022

Table 1.

Clinical features of MS and non-MS patientsa

MS (n = 23) Non-MS (n = 18) p
Mean age (range, yr) 56 (25-77) 66 (36-89) NS
M:F 11:12 9:9 NS
Disease phenotype PP-MS (n = 5)
RR-MS (n = 4)
SP-MS (n = 14)
Non-CNS disease (cancer, sepsis, myocardial infarction, drug overdose (n = 12), amyotrophic lateral sclerosis (n = 3), stroke (n = 3), multisystem atrophy (n = 1)
EDSS 4.0-9.5 NA

aMean age, sex, disease phenotype, and Expanded Disability Status Scale (EDSS) of MS (n = 23) and non-MS (n = 18) used in the present study. MS patients include primary progressive MS (PP-MS, n = 5), relapsing-remitting MS (RR-MS, n = 4), and secondary progressive MS (SP-MS, n = 14). Mann–Whitney U test was used to assess significant difference in age between MS and non-MS, and Fisher's exact test was used to assess significant difference in sex between groups.